News

Offering an empirically optimized probe database, the software’s design algorithm allows customers to acquire and evaluate designs in an automated setting before making the purchase decision. Roche Sequencing

Empagliflozin belongs to the class of sodium glucose co-transporter-2 (SGLT2) inhibitor compounds, and is being investigated for the reduction of blood glucose levels in adults with type 2

The US FDA approved Procysbi (cysteamine bitartrate) delayed-release capsules on 30 April and is indicated for adults and children with cystinosis aged six years and more. Initial prescription

Designed to optimize yield in both R&D and cGMP applications, the autoclavable bioreactors are compatible with Finesse G3Lab controllers, and SmartAdapters and can be used with third party

Designed to offer up to three days of pain relief following surgery, Posidur uses the company’s patented SABER technology to deliver bupivacaine. DURECT president and CEO James Brown

The patent covers the method of treating human diseases or disorders using PI3K and HDAC proteins, including but not restricted to CUDC-907. Designed to inhibit PI3K-alpha, delta and

The single ascending dose study will assess the safety, tolerability, pharmacokinetic and pharmacodynamic profile of BGB324. BerGenBio CEO Richard Godfrey said the Phase 1 trial of BGB324 will

PrioClear is incorporated into Octapharma’s manufacturing process for its solvent/detergent treated plasma product, Octaplas, which is currently approved for marketing in US and several European countries. The order

The new product is designed to reduce the formation of advanced glycation end-products (AGEs) associated with normal metabolism and aging. AGEs are the result of a common enzymatic